Remove 2003 Remove Biopharma Remove Competition
article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. These data are astonishing, given the perception that Big Pharma is the main driver of biopharma innovation. By 2018, that share had fallen by about half.

Pharma 105
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Org Process Res Dev 2020, 24, 10, 1996–2003. Biopharma successful in achieving climate-related goals, report finds … .

article thumbnail

How the U.S. election could impact the healthcare industries

Clarivate

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. As AG, she joined a federal lawsuit to block Anthem and Cigna’s merger in 2016.